V
Valérie Benhammou
Researcher at University of Paris
Publications - 33
Citations - 1095
Valérie Benhammou is an academic researcher from University of Paris. The author has contributed to research in topics: Population & Medicine. The author has an hindex of 12, co-authored 25 publications receiving 839 citations. Previous affiliations of Valérie Benhammou include Paris Descartes University & French Institute of Health and Medical Research.
Papers
More filters
Journal ArticleDOI
Survival and morbidity of preterm children born at 22 through 34 weeks' gestation in France in 2011: results of the EPIPAGE-2 cohort study.
Pierre-Yves Ancel,François Goffinet,Pierre Kuhn,Bruno Langer,Jacqueline Matis,Xavier Hernandorena,Pierre Chabanier,Laurence Joly-Pedespan,Bénédicte Lecomte,Françoise Vendittelli,Michel Dreyfus,Bernard Guillois,Antoine Burguet,Pierre Sagot,Jacques Sizun,Alain Beuchée,Florence Rouget,Amélie Favreau,Elie Saliba,Nathalie Bednarek,Patrice Morville,Gérard Thiriez,Loïc Marpeau,Stéphane Marret,Gilles Kayem,Xavier Durrmeyer,Michèle Granier,Olivier Baud,Pierre-Henri Jarreau,Delphine Mitanchez,Pascal Boileau,Pierre Boulot,Gilles Cambonie,Hubert Daudé,Antoine Bédu,Fabienne Mons,Jeanne Fresson,Rachel Vieux,Catherine Alberge,Catherine Arnaud,Christophe Vayssière,Patrick Truffert,Véronique Pierrat,Damien Subtil,Claude D'Ercole,Catherine Gire,Umberto Simeoni,André Bongain,Loïc Sentilhes,Jean-Christophe Rozé,Jean Gondry,André Leke,Michel Deiber,Olivier Claris,Jean-Charles Picaud,Anne Ego,Thierry Debillon,Anne Poulichet,Eliane Coliné,Anne Favre,Olivier Fléchelles,Sylvain Samperiz,Duksha Ramful,Bernard Branger,Valérie Benhammou,Laurence Foix-L’Hélias,Laetitia Marchand-Martin,Monique Kaminski +67 more
TL;DR: A substantial improvement in survival in France for newborns born at 25 through 31 weeks' gestation was accompanied by an important reduction in severe morbidity, but survival remained rare before 25 weeks, and improvement at extremely low gestational age may be possible.
Journal ArticleDOI
Association of Prenatal and Postnatal Exposure to Lopinavir-Ritonavir and Adrenal Dysfunction Among Uninfected Infants of HIV-Infected Mothers
Albane Simon,Josiane Warszawski,Dulanjalee Kariyawasam,Jérôme Le Chenadec,Valérie Benhammou,Paul Czernichow,Frantz Foissac,Kathleen Laborde,Jean-Marc Tréluyer,Ghislaine Firtion,Inès Layouni,Martine Munzer,Françoise Bavoux,Michel Polak,Stéphane Blanche +14 more
TL;DR: Postnatal treatment with a lopinavir-ritonavir-based regimen, compared with a zidovudine- based regimen, was associated with transient adrenal dysfunction among newborn children of HIV-1-infected mothers exposed in utero to lop Scandinavia.
Journal ArticleDOI
Mitochondrial dysfunction following perinatal exposure to nucleoside analogues.
TL;DR: There is no obvious reason why the fetus and newborn, often exposed for many months, should escape any such effects of antiretroviral drugs, and fetal tolerance of these drugs used during pregnancy should be carefully assessed.
Journal ArticleDOI
Incidence of cancer in children perinatally exposed to nucleoside reverse transcriptase inhibitors.
Valérie Benhammou,Josiane Warszawski,Stéphanie Bellec,François Doz,Nicolas André,Brigitte Lacour,Martine Levine,Françoise Bavoux,Roland Tubiana,Laurent Mandelbrot,Jacqueline Clavel,Stéphane Blanche +11 more
TL;DR: This study did not evidence an overall increase in cancer risk in nucleoside reverse transcriptase inhibitor exposed children until 5 years of age, and results suggesting associations with specific nucleosid reverse Transcriptase inhibitor combinations need further investigations.
Journal ArticleDOI
Preterm premature rupture of membranes at 22–25 weeks’ gestation: perinatal and 2-year outcomes within a national population-based study (EPIPAGE-2)
Elsa Lorthe,Elsa Lorthe,Elsa Lorthe,Héloïse Torchin,Pierre Delorme,Pierre-Yves Ancel,Laetitia Marchand-Martin,Laurence Foix-L’Hélias,Valérie Benhammou,Catherine Gire,Claude D'Ercole,N Winer,Loïc Sentilhes,Damien Subtil,François Goffinet,Gilles Kayem +15 more
TL;DR: Preterm premature rupture of membranes at 22–25 weeks is associated with high incidence of mortality and morbidity, with wide variations by gestational age at preterm premature rupturing membranes, however, a nonnegligible proportion of children survive without severe morbidity both at discharge and at 2 years’ corrected age.